CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smart immune cells take aim at Hard-to-Treat kidney cancer
Disease control Not yet recruitingThis early-phase study tests a new treatment called LNK001, which uses specially engineered immune cells (CAR T cells) to target and attack kidney cancer cells. The study involves 40 adults with advanced or metastatic clear cell renal cell carcinoma who have already tried other t…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New hope for kidney cancer patients with bone spread: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called zanzalintinib, taken with a bone-strengthening agent, in 20 people whose kidney cancer has spread to the bones and has worsened after prior immunotherapy. The goal is to see if the combination can stop the cancer from growing for at least 12 mon…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Immunotherapy combo before kidney surgery shows promise in early trial
Disease control Not yet recruitingThis early-phase trial is testing whether giving two immunotherapy drugs (botensilimab and balstilimab) before surgery is safe and feasible for people with high-risk clear cell kidney cancer that hasn't spread. About 16 participants will receive the drugs before their kidney remo…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Gut bacteria boost could help stop Cancer's return
Disease control Not yet recruitingThis study is testing if adding a specific probiotic (CBM588) to a standard immunotherapy drug (pembrolizumab) can better prevent kidney cancer from coming back after surgery. The trial will enroll 62 patients who have had surgery for high-risk kidney cancer. Researchers believe …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 09, 2026 19:33 UTC
-
A simple urine test could revolutionize kidney cancer diagnosis
Diagnosis Not yet recruitingThis study aims to find protein markers in urine and blood that can help doctors identify different types of kidney cancer without needing a tissue biopsy. Researchers will analyze stored urine samples and collect blood from 300 patients before and after kidney surgery. The goal …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 26, 2026 03:15 UTC
-
New study aims to unlock bone immune secrets in kidney cancer
Knowledge-focused Not yet recruitingThis early-phase study looks at how the drug cabozantinib changes the immune environment inside bone tumors in people with kidney cancer that has spread to the bone. The goal is to learn which treatments work best to prevent bone complications and improve outcomes. Sixteen partic…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 03:19 UTC